Insider trading

Period: 12 months Stock: IRWD Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

14 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

14 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

14 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

14 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
14 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
14 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

14 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
17 Mar 2026
DENNER ALEXANDER J Director · indirect
Sold at will 2×
$20.53M 6,730,800 at 3.05
42.3%
Not planned
24 Feb 2026
MCCOURT Thomas A Chief Executive Officer
Sold at will
$378.91K 103,526 at 3.66
6.5%
Not planned
24 Feb 2026
John Minardo Chief Legal Officer
Sold at will
$69.73K 19,053 at 3.66
5.0%
Not planned
24 Feb 2026
Shetzline Michael SVP, CMO, Head-Res&Drug
Bought
$62.26K 17,012 at 3.66
3.4%
First buy on file
24 Feb 2026
Silver Ronald Principal Accounting Officer
Sold at will
$46.19K 12,621 at 3.66
4.8%
Not planned
24 Feb 2026
Martini Gregory S. Chief Financial Officer
Sold at will
$41.93K 11,457 at 3.66
6.7%
Not planned
24 Feb 2026
Gaskins Tammi L Chief Commercial Officer
Sold at will
$41.13K 11,239 at 3.66
5.0%
Not planned
23 Feb 2026
MCCOURT Thomas A Chief Executive Officer
Sold at will
$361.02K 94,757 at 3.81
5.6%
Not planned
23 Feb 2026
John Minardo Chief Legal Officer
Sold at will
$66.44K 17,439 at 3.81
4.4%
Not planned
23 Feb 2026
Shetzline Michael SVP, CMO, Head-Res&Drug
Sold at will
$59.32K 15,570 at 3.81
2.8%
Not planned
23 Feb 2026
Silver Ronald Principal Accounting Officer
Sold at will
$44.01K 11,552 at 3.81
4.2%
Not planned
23 Feb 2026
Martini Gregory S. Chief Financial Officer
Sold at will
$39.96K 10,487 at 3.81
5.7%
Not planned
23 Feb 2026
Gaskins Tammi L Chief Commercial Officer
Sold at will
$39.19K 10,287 at 3.81
4.4%
Not planned
17 Nov 2025
Gaskins Tammi L Chief Commercial Officer
Sold at will
$19.97K 6,016 at 3.32
2.5%
Not planned
Showing 1–14 of 14.